PACB - PacBio moved to Neutral at JPMorgan after guidance cut April, 22 2024 08:50 AM Pacific Biosciences of California Inc. 2024-04-22 08:50:58 ET PacBio ( NASDAQ: PACB ) is facing yet another downgrade after the gene sequencing company lowered its full-year outlook, while missing Q1 results .... For further details see: PacBio moved to Neutral at JPMorgan after guidance cut